Healthcare organizations are investing rapidly in AI and advanced analytics, yet many struggle to translate clinical data into tools that are safe, equitable, and useful in real care settings.
AX-0810 clinical target engagement data in healthy volunteers on track for this quarter; biliary atresia selected as initial Phase 2 indicationAdditional programs advancing toward the clinic, ...
Viking Therapeutics has reached a significant clinical milestone, completing patient enrollment for its second Phase 3 trial. With the VANQUISH-2 study now full ...
CytomX Therapeutics, Inc. (NASDAQ:CTMX) is one of the popular penny stocks on Robinhood to buy. On March 23, Piper Sandler analyst Joseph Catanzaro raised his price target on CytomX Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results